Redeye provides its initial take on Lifco’s Q4 2025 report, which missed our projections by 3% on sales and 5% on EBITA. The miss was driven by lower organic growth in Dental and Demolition & Tools in conjunction with a slightly higher FX headwind than we anticipated. The company’s organic growth remains solid, and cash flow in Q4 was strong.
LÄS MER
